Dergiler / Pediatric Practice and Research / 2026 / Volume: 9 Issue: 2

Treatment approaches in ovarian masses in children

Kübra Ertan(Department of Pediatrics, Selcuk University, Faculty of MedicineSELÇUK ÜNİVERSİTESİ TIP FAKÜLTESİ)
Mehmet Sarıkaya(Department of Pediatric Surgery, Selcuk University, Faculty of Medicine)0000-0003-2453-0893
Hilal Akbaş(Department of Pediatric Hematology and Oncology, Ministry of Health Konya City Hospital, Hamidiye Faculty of Medicine, Saglik Bilimleri University)0000-0003-3938-709X
Fatma Özcan Sıkı(Department of Pediatric Surgery, Ministry of Health Konya City Hospital, Hamidiye Faculty of Medicine, Saglik Bilimleri University)0000-0002-4461-3461
Buket Kara(Department of Pediatric Hematology and Oncology, Selcuk University, Faculty of Medicine)
Sayfa
—
Yayın Tarihi
2021-08-31
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In malignant tumors, overall survival rates have increased with multidisciplinary approaches.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The aim of this retrospective study is to evaluate clinical features, treatment approaches and outcomes of children with ovarian mass.
📊
Temel Bulgular & Veri:Materials and Methods: In our clinic, the oncologic charts of children with a mass in the ovary between 2009 and 2020 were analyzed retrospectively.
💡
Sonuç & Katkı:In malignant tumors, overall survival rates have increased with multidisciplinary approaches.
🔬Tür:Research Article
📍Kapsam:2009 Verileri
⚙️Değişkenler:children · ovary · mass

Abstract

Aim: The aim of this retrospective study is to evaluate clinical features, treatment approaches and outcomes of children with ovarian mass. Materials and Methods: In our clinic, the oncologic charts of children with a mass in the ovary between 2009 and 2020 were analyzed retrospectively. The patients' demographic features, symptoms and signs, diagnosis, treatments and outcomes were noticed. Results: The age of 55 patients included in the study ranged from two months to 18 years (median, 12.9 years). While the ages of 38 patients were ≥ 10 years (69.1%), 17 of them were <10 years (30.9%). Fifty of the patients underwent elective surgery (91%), four had emergency surgery (7.3%), one patient's family refused the treatment (1.8%). Of the surgeries performed, 28 were salpingo-oophorectomy (51.9%), 23 were oophorectomy (42.6%), and 3 were cystectomy (5.6%). The types of ovarian mass were germ cell tumors (n: 44, 80%), epithelial tumors (n: 4, 7.3%), stromal tumors (n: 3, 5.5%), simple cyst (n: 2, 3.6%), and others (n: 2, 3.6%). Two patients with malignant tumor (one dysgerminoma patient with ataxia telangiectasia, and the other with yolk sac tumor) died while the others were alive. Conclusion: In children, benign tumors are more prominent and surgical treatment is sufficient. In malignant tumors, overall survival rates have increased with multidisciplinary approaches.

Anahtar kelimeler
🔖

Bu Makaleye Atıf Yap

Ertan, K., Sarıkaya, M., Akbaş, H., Sıkı, F. Ö., Kara, B. (2021). Treatment approaches in ovarian masses in children. Pediatric Practice and Research, Volume: 9 Issue: 2. https://doi.org/10.21765/pprjournal.877251

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (19)

  1. Kelleher CM, Goldstein AM. Adnexal masses in children and adolescents. Clin Obstet Gynecol. 2015; 58(1):76-92.
  2. Hermans AJ, Kluivers KB, Wijnen MH, Bulten J, Massuger LF, Coppus SF. Diagnosis and treatment of adnexal masses in children and adolescents. Obstet Gynecol. 2015; 125(3): 611-5.
  3. Schultz KA, Ness KK, Nagarajan R, Steiner ME. Adnexal masses in infancy and childhood. Clin Obstet Gynecol. 2006; 49(3): 464-79.
  4. van Winter JT, Simmons PS, Podratz KC. Surgically treated adnexal masses in infancy, childhood, and adolescence. Am J Obstet Gynecol. 1994; 170(6): 1780-6.
  5. Sonmez K, Turkyilmaz Z, Karabulut R, Can Basaklar A. Ovarian masses in infant-juvenile age. Arch Argent Pediatr. 2018; 116(3): e359-e364.
  6. Koksal Y, Reisli I, Gunel E, Caliskan U, Bulun A, Kale G. Galactorrhea-associated granulosa cell tumor in a child. Pediatr Hematol Oncol. 2004; 21(2):101-6.
  7. Savic D, Stankovic ZB, Djukic M, Mikovic Z, Djuricic S. Torsion of malignant ovarian tumors in childhood and adolescence. J Pediatr Endocrinol Metab. 2008; 21(11): 1073-8.
  8. Pedrazzoli P, Rosti G, Soresini E, Ciani S, Secondino S. Serum tumour markers in germ cell tumours: from diagnosis to cure. Crit Rev Oncol Hematol. 2021: 103224.
  9. Rathore R, Sharma S, Arora D. Spectrum of childhood and adolescent ovarian tumors in India: 25 years experience at a single institution. Open Access Maced J Med Sci. 2016; 4(4): 551-5.
  10. Morowitz M, Huff D, von Allmen D. Epithelial ovarian tumors in children: a retrospective analysis. J Pediatr Surg. 2003; 38(3):331-5.
  11. Akyuz C, Varan A, Buyukpamukcu N, Kutluk T, Buyukpamukcu M. Malignant ovarian tumors in children: 22 years of experience at a single institution. J Pediatr Hematol Oncol. 2000; 22(5): 422-7.
  12. Young RH, Kozakewich HP, Scully RE. Metastatic ovarian tumors in children: a report of 14 cases and review of the literature. Int J Gynecol Pathol. 1993; 12(1):8-19.
  13. Patte C, Auperin A, Michon J, et al. Société Française d'Oncologie Pédiatrique. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001; 97(11):3370-9.
  14. Singla V, Prabhakar N, Khandelwal N, et al. Role of perfusion CT in the evaluation of adnexal masses. J Obstet Gynaecol. 2019; 39(2): 218-23.
  15. Ishiguro T, Yoshida Y, Tenzaki T, Ohshima M, Suzuki H. AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP. Cancer. 1981; 48(11): 2480-4.
  16. Piippo S, Mustaniemi L, Lenko H, Aine R, Mäenpää J. Surgery for ovarian masses during childhood and adolescence: a report of 79 cases. J Pediatr Adolesc Gynecol. 1999; 12(4): 223-7.
  17. How JA, Marino JL, Grover SR, et al. Surgically managed ovarian masses at the Royal Children's Hospital, Melbourne -19-year experience. J Pediatr Surg. 2019; 54(9):1913-20.
  18. Schultz KA, Sencer SF, Messinger Y, Neglia JP, Steiner ME. Pediatric ovarian tumors: a review of 67 cases. Pediatr Blood Cancer. 2005; 44(2):167-73.
  19. Koksal Y, Caliskan U, Ucar C, et al. Dysgerminoma in a child with ataxia-telangiectasia. Pediatr Hematol Oncol. 2007; 24(6):431-6.